Maestas Nicholas 4
4 · Tempest Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Maestas Nicholas
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-03+38,425→ 38,425 totalExercise: $1.23Exp: 2033-01-02→ Common Stock (38,425 underlying)
Footnotes (1)
- [F1]These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service.